(Q47602948)

4 February 2018

title

Quality of life in endometrial cancer survivors (English)

1 reference

4 February 2018

1 reference

1 reference

Li C

1

1 reference

4 February 2018

Samsioe G

series ordinal

2

1 reference

4 February 2018

Iosif C

series ordinal

3

1 reference

4 February 2018

publication date

1 March 1999

1 reference

4 February 2018

published in

Maturitas

1 reference

4 February 2018

volume

31

1 reference

4 February 2018

issue

3

1 reference

4 February 2018

page(s)

227-236

1 reference

4 February 2018

cites work

Cancer statistics, 1996.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900106-6

7 January 2021

Reproductive health, use of estrogen and experience of symptoms in perimenopausal women: a population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900106-6

7 January 2021

The impact of a psychological intervention on quality of life in non-metastatic breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900106-6

7 January 2021

Symptom control in psychosocial oncology

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900106-6

7 January 2021

The psychiatrist's perspective on quality of life and quality of care in oncology: concepts, symptom management, communication issues

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900106-6

7 January 2021

Quality of life after the menopause: influence of hormonal replacement therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900106-6

7 January 2021

A new methodological approach to the evaluation of quality of life in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900106-6

7 January 2021

Estrogen replacement therapy: is previously treated cancer a contraindication?

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900106-6

7 January 2021

Hormone therapy following breast and uterine cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900106-6

7 January 2021

Hormone replacement therapy in the menopause: a pro opinion

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900106-6

7 January 2021

Estrogen replacement therapy following treatment for stage I endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900106-6

7 January 2021

Administration of estrogens to patients with a previous diagnosis of endometrial adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900106-6

7 January 2021

Estrogen replacement in surgical stage I and II endometrial cancer survivors

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900106-6

7 January 2021

Hormonal replacement therapy in patients after cervical cancer treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900106-6

7 January 2021

10.1016/S0378-5122(98)00106-6

Identifiers

DOI

1 reference

4 February 2018

1 reference

4 February 2018